Immune-based therapies.
Lein
B
B
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015316:Genetic Therapy; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D019469:Indinavir; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D017320:HIV Protease Inhibitors; D016898:Interferon-alpha; D007376:Interleukin-2; D011725:Pyridines; D019469:Indinavir